Skip to content

Bioalmanac

TB-500

Thymosin beta-4 fragment · TB4 fragment

Preclinical

Status reviewed 12 Aug 2026

Prohibited in sport

A synthetic fragment of thymosin beta-4, a naturally occurring protein involved in cell migration and tissue repair. Animal evidence only.

Storage

Freeze-dried powder
Refrigerated at 2–8 °C, protected from light.
After mixing
Refrigerated at 2–8 °C. Do not freeze once mixed.
Long-term, frozen
Unopened lyophilised powder is stable at −20 °C or colder for considerably longer than refrigeration allows.

Reconstitution — 5 mg vial, 2500 mcg dose

On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.

Water addedConcentrationVolume to drawUnitsDoses per vial
1 mL5 mg/mL0.5 mL50 units2
2 mL2.5 mg/mL1 mL100 units2
3 mL1.667 mg/mLExceeds a 1 mL barrel
5 mL1 mg/mLExceeds a 1 mL barrel

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Loading, commonly described2000–5000 mcgTwice weekly for the first four to six weeksCommunity practice
Maintenance, commonly described2000–2500 mcgOnce weekly or every other weekCommunity practice

When to stop

  • Signs of infection at an injection site: spreading redness, warmth, swelling, pus, or fever.
  • Any allergic response: rash, hives, facial or lip swelling, or difficulty breathing. Seek urgent care.
  • Any new lump, growth or unexplained change you would ordinarily have investigated.
  • Before planned surgery, and tell your surgical team.

Not approved for human use in the United States. Sold only as a research chemical, with no manufacturing standard behind that label.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/tb-500

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.